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Robert Zivadinov1,2Abstract
The extracranial venous system is complex and variable between individuals. Until recently, these variations were
acknowledged as developmental variants and were not considered pathological findings. However, in the last
decade, the presence and severity of uni- or bi-lateral jugular venous reflux (JVR) was linked to several central
nervous system (CNS) disorders such as transient global amnesia, transient monocular blindness, cough headache,
primary exertional headache and, most recently, to Alzheimer's disease. The most recent introduction of a
composite criteria-based vascular condition named chronic cerebrospinal venous insufficiency (CCSVI), which was
originally linked to multiple sclerosis, increased the interest in better understanding the role of the extracranial
venous system in the pathophysiology of CNS disorders. The ultimate cause-consequence relationship between
these conditions and CNS disorders has not been firmly established and further research is needed. The purpose of
this article collection in BMC Medicine and BMC Neurology is to synthesize current concepts and most recent
findings concerning the evaluation, etiology, pathophysiology and clinical relevance of the potential involvement of
the extracranial venous system in the pathology of multiple CNS disorders and in aging.
Please see related debate: http://www.biomedcentral.com/1741-7015/11/260.
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The potential involvement of the extracranial venous
system in the pathology of central nervous system
(CNS) disorders and in aging is largely debated at this
time [1,2]. This is primarily because the role of venous
drainage impairment, for example, extracranial venous
abnormalities, is largely unknown and because the ven-
ous system is subject to many variations [1-4]. However,
the knowledge has been rapidly changing with regards
to the role of the extracranial venous system in relation
to CNS pathology. This is because a range of extracra-
nial venous abnormalities that disrupt normal blood flow
and are characterized with the development of promin-
ent collateral circulation, have recently been associated
with a number of CNS disorders and aging [3,5-8].Correspondence: rzivadinov@bnac.net
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2013The extracranial venous system is complex with vari-
ability between individuals and is frequently asymmetric
[3]. Until recently, these variations were acknowledged
as developmental variants and were not considered
pathological findings [9]. In the last decade, the presence
and severity of uni- or bi-lateral jugular venous reflux (JVR)
was linked to several CNS disorders, such as transient glo-
bal amnesia, transient monocular blindness, cough head-
ache, primary exertional headache and, most recently, to
Alzheimer's disease [8,10-16]. However, the most recent
introduction of a composite criteria-based vascular condi-
tion named chronic cerebrospinal venous insufficiency
(CCSVI) [6] increased the interest in better understanding
the role of the extracranial venous system in the pathophysi-
ology of CNS disorders [5]. CCSVI is characterized by extra-
cranial cerebrospinal venous outflow abnormalities of the
main routes that may interfere with normal venous outflow.
These anomalies were described in the internal jugular veins
(IJVs), the vertebral veins and the azygos vein.
The debate article by Zivadinov and Chung [5] pro-
vides a timely update about the anatomy, etiology and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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normalities/developmental variants and their potential
involvement with CNS pathology. A classification of ex-
tracranial venous abnormalities/developmental variants
that is independent of any single diagnostic imaging mo-
dality is presented. These can be classified as structural/
morphological, hemodynamic/functional and those de-
termined only by the composite criteria and use of
multimodal imaging. Furthermore, structural/morpho-
logical venous abnormalities are divided into those creat-
ing narrowing or occlusion and those causing abnormal
distensibility, whereas hemodynamic functional venous
abnormalities are classified as abnormal cerebral ven-
ous outflow in the presence or absence of a structural
venous anomaly in the extracranial veins. Zivadinov
and Chung point out that one of the central issues to
be further investigated is the definition of the signifi-
cant narrowing of the extracranial venous system with
hemodynamic consequences for the intracranial venous
drainage. They critically report that the current definition
(narrowing of >50% in respect to the proximal adjacent
vein segment) is mainly derived from observations in the
arterial system and is, therefore, probably inadequate for
the venous system. The article also examines the associ-
ation of these venous abnormalities, as well as their clinical
correlates in relation to various CNS disorders and aging.
Two other original articles of this article collection examine
the relationship between the presence and severity of
CCSVI and cognitive dysfunction in patients with multiple
sclerosis (MS) [17,18]. Benedict et al. examined 109 MS
patients and found no evidence of an association between
the presence and severity of CCSVI with cognitive impair-
ment and depression in patients with MS [17], while Leone
et al. evaluated 61 MS patients and found no association
between CCSVI and cognitive impairment, fatigue, depres-
sion, bladder/sexual symptoms and self-reported quality of
life [18]. These findings are corroborating numerous other
recent clinical and magnetic resonance imaging (MRI)
studies that showed no evidence of a clinical association
between CCSVI and MS [19,20].
The limited understanding of the pathophysiology of
the extracranial venous system may consequently under-
estimate the impact of cerebral venous drainage abnor-
malities in a variety of CNS disorders [5]. Because of
this, there is a need for more basic science and clinical
studies to increase our knowledge and understanding of
the clinical association and pathophysiologies of cerebral
venous drainage abnormalities. In the review article by
CB Beggs [21], the author discusses the pathophysiology
regarding venous abnormalities in MS, leukoaraiosis and
normal-pressure hydrocephalus (NPH). The review is
supplemented with a hydrodynamic analysis to assess
the effects on cerebrospinal fluid (CSF) dynamics and
cerebral blood flow (CBF) of venous hypertension ingeneral and CCSVI in particular. An obstruction of the
extracranial venous drainage pathways may result in
hypoxia. It is underlined that the hydrodynamic proper-
ties of the periventricular veins make these vessels
particularly vulnerable to ischemia and plaque formation
which may explain their frequent involvement in MS,
leukoaraiosis and other neurodegenerative CNS diseases.
The review also provides evidence that venous hyperten-
sion in the dural sinuses can alter intracranial compli-
ance and change the CSF dynamics which is observed
both in patients with MS and NPH.
One of the most convincing indicators towards a “vas-
cular origin” for MS comes from neuropathological
observations showing that MS plaques are exclusively
perivenular and dimensions of the veins determine the
shape, course and dimension of the lesions [22]. This is
supported by recent imaging studies showing that a ma-
jority of MS lesions are associated with centrally cours-
ing veins [23]. Such findings raise fundamental questions
about the nature of this disease, that is, why their
pathognomonic lesions do not develop around the arter-
ies and what exactly are the roles of cerebral venous
inflammation in their pathogenesis. A review article by
Alexander et al. [24] presents a comprehensive review of
the pathophysiology of MS, acute disseminated enceph-
alomyelitis, pseudotumor cerebri and optic neuritis, with
an emphasis on the roles of venous vascular system pro-
gramming and dysfunction in their pathogenesis. They
consider the fundamental differences between arterial
and venous endothelium their dissimilar responses to in-
flammation and the potential theoretical contributions
of chronic venous insufficiency in the pathogenesis of
neurovascular diseases.
The pathophysiology of extracranial venous abnormal-
ities may be further elucidated by exploring the role of
precipitating risk factors [2,5,25,26]. The incidence and
prevalence of extracranial venous abnormalities should
be determined in relation to embryologic/developmen-
tal arrest factors, demographic factors (such as age,
sex, race), cardiovascular risk factors (smoking, obes-
ity, hypertension, diabetes, hyperlipidemia), inflamma-
tory comorbidities and other possible precipitating risk
factors, such as one’s level of exercise and diet [5]. In
an original article, Chung et al. [27] tested the hypoth-
esis that JVR, in addition to an increased level of
plasma endothelin-1 (ET-1), a potent vasoconstrictor,
is involved in the pathophysiology of cough syncope in
17 cough syncope or pre-syncope patients and in 51
age- and sex-matched healthy controls. The authors
showed a synergistic effect between JVR and plasma
ET-1 levels on the occurrence of cough syncope/pre-
syncope. This is indeed an interesting finding, as it
suggests that extracranial venous abnormality per se is
not sufficient to increase the hydraulic resistance of
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must be at work, including the potential role of various
precipitating risk factors.
At this time, there is no established diagnostic imaging
modality, non-invasive or invasive, that can serve as the
“gold standard” for the detection of any extracranial ven-
ous abnormalities [3]. However, consensus guidelines
and standardized imaging protocols are emerging. Dolic
et al. provide a comprehensive review of non-invasive
and invasive imaging methods for the detection of extra-
cranial venous abnormalities, including CCSVI [3]. They
describe in detail the advantages and disadvantages of
non-invasive imaging modalities such as Doppler son-
ography, magnetic resonance venography, computed
tomography venography and plethysmography, as well as
invasive imaging methods, including catheter venography
and intravascular sonography. The article emphasizes
the need for the use of composite criteria by uni- or
multi-modal imaging modalities of the extracranial
venous system because it is almost impossible to deter-
mine the relevance of a single structural/morphologic
or hemodynamic/functional venous abnormality, regardless
of the imaging modality or methodology utilized. In
fact, in an original article, Zivadinov et al. evaluated
the non-invasive and invasive multimodal imaging cor-
relates of 20 MS patients with relapsing MS who were
enrolled in the Prospective Randomized Endovascular
therapy in Multiple Sclerosis” (PREMiSe) study [28].
They conclude that both a non-invasive and invasive
multimodal imaging diagnostic approach should be
recommended to depict a range of extracranial venous
anomalies indicative of CCSVI.
When there is narrowing of the principal pathways of
the extracranial venous system, collateral veins usually
form as physiological secondary compensation for the
compromised venous system outflow [3,4]. The presence
of collateral flows, from a biomechanical point of view,
is the strongest evidence for constricted principal venous
pathways and venous hypertension. In an original pilot
study, Zamboni et al. present a novel model in a clinical
setting that suggests the pivotal role of the collateral net-
work in draining the blood into the superior vena cava
under CCSVI conditions [29]. One of the fundamental
issues to be further investigated when determining the
impact of significant extracranial venous narrowing is
the degree of collateral circulation compensation.
While a link between the presence and severity of ex-
tracranial venous abnormalities and several CNS disor-
ders as well as aging is emerging, it is to be determined
whether those may play a potential role, as precipitating
factors, to increased susceptibility for a number of CNS
disorders. Although the presence and severity of JVR
and CCSVI have been linked to a number of CNS disor-
ders, the ultimate cause-consequence relationship hasnot been firmly established. In an original article, Cheng
et al. showed in 23 transient monocular blindness
(TMB) patients who had no carotid stenosis and in 23
age- and sex-matched healthy controls that there was a
greater severity of IJV compression/stenosis in TMB pa-
tients [11]. Therefore, there is a future need for a better
understanding of the role of extracranial venous abnor-
malities but many questions remain unanswered at this
time. Because of this, the endovascular treatment for the
correction of these extracranial venous abnormalities
should be discouraged at this time, until the potential
benefit is demonstrated in properly-designed blinded,
randomized and controlled clinical trials.
The ‘Venous Involvement in Neurological Disorders
and Aging’ article collection in BMC Medicine and BMC
Neurology has attempted to present a fair and balanced
discussion of the examined topics. It is hoped that the
contents of this collection will encourage the readers to
continue their research on this subject.
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